Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A. muciniphila strain (WST01) are currently being tested in a human cohort with overweight and T2DM as part of a 12week ongoing phase II clinical trial for which the primary outcome is the evaluation of effects on body weight and fasting plasma glucose levels
see also:
Akkermansia muciniphila & Ulcerative Colitis (UC)
…